Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial

Malou C. Herman, Marian J. van den Brink, Peggy M. Geomini, Hannah S. van Meurs, Judith A. Huirne, Heleen P. Eising, Anne Timmermans, Johanna M. A. Pijnenborg, Ellen R. Klinkert, Sjors F. Coppus, Theodoor E. Nieboer, Ruby Catshoek, Lucet F. van der Voet, Hugo W. F. van Eijndhoven, Giuseppe C. M. Graziosi, Sebastiaan Veersema, Paul J. van Kesteren, Josje Langenveld, Nicol A. C. Smeets, Huib A. A. M. van VlietJan Willem van der Steeg, Yvonne Lisman-van Leeuwen, Janny H. Dekker, Ben W. Mol, Marjolein Y. Berger, Marlies Y. Bongers

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)


Heavy menstrual bleeding is an important health problem. Two frequently used therapies are the levonorgestrel intra-uterine system (LNG-IUS) and endometrial ablation. The LNG-IUS can be applied easily by the general practitioner, which saves costs, but has considerable failure rates. As an alternative, endometrial ablation is also very effective, but this treatment has to be performed by a gynaecologist. Due to lack of direct comparison of LNG-IUS with endometrial ablation, there is no evidence based preferred advice for the use of one of these treatment possibilities. A multicenter randomised controlled trial, organised in a network infrastructure in the Netherlands in which general practitioners and gynaecologists collaborate. This study, considering both effectiveness and cost effectiveness of LNG-IUS versus endometrial ablation may well improve care for women with heavy menstrual bleeding. Dutch trial register, number NTR2984
Original languageEnglish
Article number32
Pages (from-to)32
JournalBMC Women's health
Issue number1
Publication statusPublished - 2013

Cite this